Actively Recruiting
A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis
Led by Ain Shams University · Updated on 2025-07-28
160
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Aim of this study is to predict the prognostic values of Neutrophil/ Lymphocyte ratio and Lactate/Albumin ratio in the outcome of patients with sepsis and septic shock with lower respiratory tract infection, also to compare between them regarding sensitivity and specificity.
CONDITIONS
Official Title
A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults with lower respiratory tract infection
- Confirmed septic patients under the third international consensus definitions of sepsis and septic shock
- Admitted to intensive care unit
- Age between 18 and 80 years
- Both genders
You will not qualify if you...
- Age under 18 years or over 80 years
- Patient refusal to participate
- Pregnancy
- Malignancy
- Conditions affecting serum albumin before ICU admission, including malnutrition, nephrotic syndrome, liver cirrhosis, or intestinal resection surgeries
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ain Shams university
Cairo, Abbassia, Egypt, 00202
Actively Recruiting
Research Team
A
Ahmed Gamal Ahmed, M.BB.CH,M.Sc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here